Gainers

• Cyclerion Therapeutics (NASDAQ:CYCN) shares increased by 52.9% to $2.11 during Tuesday's pre-market session. The company's market cap stands at $5.2 million.
• Alumis (NASDAQ:ALMS) shares rose 18.65% to $9.86. The company's market cap stands at $867.5 million.
• Kala Bio (NASDAQ:KALA) shares rose 14.1% to $0.7. The company's market cap stands at $6.6 million.
• Genprex (NASDAQ:GNPX) stock rose 13.88% to $2.05. The market value of their outstanding shares is at $4.0 million.
• Prelude Therapeutics (NASDAQ:PRLD) stock increased by 12.29% to $2.74. The market value of their outstanding shares is at $153.3 million.
• Bright Minds Biosciences (NASDAQ:DRUG) stock moved upwards by 9.98% to $88.0. The company's market cap stands at $623.0 million.

Losers

• Inspira Technologies Oxy (NASDAQ:IINN) stock fell 7.2% to $0.92 during Tuesday's pre-market session. The company's market cap stands at $35.6 million.
• InMed Pharmaceuticals (NASDAQ:INM) shares decreased by 6.96% to $1.07. The market value of their outstanding shares is at $3.2 million.
• Mustang Bio (NASDAQ:MBIO) stock declined by 5.41% to $1.05. The market value of their outstanding shares is at $8.1 million.
• Zenas BioPharma (NASDAQ:ZBIO) shares decreased by 5.0% to $15.78. The company's market cap stands at $891.6 million.
• Redhill Biopharma (NASDAQ:RDHL) shares declined by 5.0% to $1.33. The market value of their outstanding shares is at $7.1 million.
• Inspire Veterinary (NASDAQ:IVP) stock fell 4.43% to $0.05. The market value of their outstanding shares is at $2.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.